Compare UNCY & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNCY | CLIR |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.4M | 33.4M |
| IPO Year | 2021 | 2012 |
| Metric | UNCY | CLIR |
|---|---|---|
| Price | $5.78 | $0.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $44.50 | $2.00 |
| AVG Volume (30 Days) | ★ 343.1K | 122.8K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,153,000.00 |
| Revenue This Year | N/A | $13.13 |
| Revenue Next Year | N/A | $143.88 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.71 | $0.46 |
| 52 Week High | $11.00 | $1.60 |
| Indicator | UNCY | CLIR |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 39.13 |
| Support Level | $5.69 | $0.55 |
| Resistance Level | $6.30 | $0.65 |
| Average True Range (ATR) | 0.34 | 0.05 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 37.70 | 11.09 |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.